Background Image
Table of Contents Table of Contents
Previous Page  93 / 168 Next Page
Information
Show Menu
Previous Page 93 / 168 Next Page
Page Background

Datasonic Group Berhad

(Company No. 809759-X)

91

NOTES TO THE FINANCIAL STATEMENTS

for the financial year ended 31 March 2016

(Continued)

4.

SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

4.10 IMPAIRMENT

(a) Impairment of Financial Assets

All financial assets (other than those categorised at fair value through profit or loss), are

assessed at the end of each financial year whether there is any objective evidence of

impairment as a result of one or more events having an impact on the estimated future

cash flows of the asset. For an equity instrument, a significant or prolonged decline in the

fair value below its cost is considered to be an objective evidence of impairment.

An impairment loss in respect of held-to-maturity investments and loans and receivables

financial assets is recognised in profit or loss and is measured as the difference between the

asset’s carrying amount and the present value of estimated future cash flows, discounted

at the financial asset’s original effective interest rate.

An impairment loss in respect of available-for-sale financial assets is recognised in

profit or loss and is measured as the difference between its cost (net of any principal

payment and amortisation) and its current fair value, less any impairment loss previously

recognised. In addition, the cumulative loss recognised in other comprehensive income

and accumulated in equity under fair value reserve, is reclassified from equity into profit

or loss.

With the exception of available-for-sale debt instruments, if, in a subsequent period, the

amount of the impairment loss decreases and the decrease can be related objectively

to an event occurring after the impairment was recognised, the previously recognised

impairment loss is reversed through profit or loss to the extent that the carrying amount

financial asset at the date the impairment is reversed does not exceed what the amortised

cost would have been had the impairment not been recognised. In respect of available-

for-sale equity instruments, impairment losses previously recognised in profit or loss are not

reversed through profit or loss. Any increase in fair value subsequent to an impairment loss

made is recognised in other comprehensive income.

An impairment loss in respect of unquoted equity instrument that is carried at cost is

recognised in profit or loss and is measured as the difference between the financial asset’s

carrying amount and the present value of estimated future cash flows discounted at the

current market rate of return for a similar financial asset. Such impairment losses are not

reversed in subsequent periods.

(b) Impairment of Non-Financial Assets

The carrying values of assets, other than those to which MFRS 136 - Impairment of Assets

does not apply, are reviewed at the end of each financial year for impairment when an

annual impairment assessment is compulsory there is an indication that the assets might

be impaired. Impairment is measured by comparing the carrying values of the assets with

their recoverable amounts. When the carrying amount of an asset exceeds its recoverable

amount, the asset is written down to its recoverable amount and an impairment loss shall

be recognised. The recoverable amount of the assets is the higher of the assets' fair value

less costs to sell and their value-in-use, which is measured by reference to discounted

future cash flow using a pre-tax discount rate.